EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in Pyrimidine-Based Drugs

Baskar Nammalwar, Richard A Bunce iD

Pharmaceuticals · 11.01.2024 · 17 (1) · 104

DOI: 10.3390/ph17010104 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 11.01.2024. Verfasst von Baskar Nammalwar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Vividion Therapeutics, 5820 Nancy Ridge Drive, San Diego, CA 92121, USA. Die Arbeit wurde bisher 162-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pyrimidines have become an increasingly important core structure in many drug molecules over the past 60 years. This article surveys recent areas in which pyrimidines have had a major impact in drug discovery therapeutics, including anti-infectives, anticancer, immunology, immuno-oncology, neurological disorders, chronic pain, and diabetes mellitus. The article presents the synthesis of the medicinal agents and highlights the role of the biological target with respect to the disease model. Additionally, the biological potency, ADME properties and pharmacokinetics/pharmacodynamics (if available) are discussed. This survey attempts to demonstrate the versatility of pyrimidine-based drugs, not only for their potency and affinity but also for the improved medicinal chemistry properties of pyrimidine as a bioisostere for phenyl and other aromatic π systems. It is hoped that this article will provide insight to researchers considering the pyrimidine scaffold as a chemotype in future drug candidates in order to counteract medical conditions previously deemed untreatable.

Schlagwörter

Stichwörter der Autor:innen

anti-inflammatoryantibioticanticancerantifungalantiviralbuilding blockchronic paindiabetes mellitusimmunological treatmentneurological disorderspyrimidines

Autor:innen und Institutionen

  • Vividion Therapeutics, 5820 Nancy Ridge Drive, San Diego, CA 92121, USA.
  • Department of Chemistry, Oklahoma State University, Stillwater, OK 74078, USA.

ORCID-Profile: Richard A Bunce

Zitieren

APA

Nammalwar, B., & Bunce, R. A. (2024). Recent Advances in Pyrimidine-Based Drugs. Pharmaceuticals, 17(1), 104. https://doi.org/10.3390/ph17010104

Vancouver

Nammalwar B, Bunce RA. Recent Advances in Pyrimidine-Based Drugs. Pharmaceuticals. 2024;17(1):104. doi:10.3390/ph17010104

BibTeX
@article{Nammalwar2024,
  author = {Nammalwar, Baskar and Bunce, Richard A},
  title = {Recent Advances in Pyrimidine-Based Drugs},
  journal = {Pharmaceuticals},
  year = {2024},
  volume = {17},
  number = {1},
  pages = {104},
  doi = {10.3390/ph17010104}
}
Kostenlos starten →